Get started
Author

Beatrix Mutschlechner

Observed names: B Mutschlechner, B. Mutschlechner, BEATRIX MUTSCHLECHNER
ORCID: 0000-0002-0576-6342
Observed ORCID: 0000-0002-0576-6342
OpenAlex ID: A5016245458
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
2022 · Jonathan P Piccini, Valeria Caso, et al. · The Lancet · 346
PDF
The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients
2021 · Emanuel Zitt, Tamara Davidovic, et al. · Frontiers in Immunology · 63
PDF
Serological SARS‐CoV‐2 antibody response, potential predictive markers and safety of BNT162b2 mRNA COVID‐19 vaccine in haematological and oncological patients
2021 · Magdalena Benda, Beatrix Mutschlechner, et al. · British Journal of Haematology · 55
PDF
Efficacy and safety of heterologous booster vaccination with Ad26.COV2.S after BNT162b2 mRNA COVID‐19 vaccine in haemato‐oncological patients with no antibody response
2021 · Patrick Reimann, Hanno Ulmer, et al. · British Journal of Haematology · 41
Preoperative Assessment of Muscle Mass Using Computerized Tomography Scans to Predict Outcomes Following Orthotopic Liver Transplantation
2019 · Hannah Esser, Thomas Resch, et al. · Transplantation · 33
PDF
SARS-CoV-2 RBD-specific and NP-specific antibody response of healthcare workers in the westernmost Austrian state Vorarlberg: a prospective cohort study
2022 · Michele Atzl, Axel Muendlein, et al. · BMJ Open · 5
PDF
Immunotherapy pitfall: sarcoid-like reaction mimicking disease progression in advanced melanoma treated with nivolumab
2022 · Beatrix Mutschlechner, Susanne Dertinger, et al. · memo - Magazine of European Medical Oncology · 2
Abstract 8937: Type 2 Diabetes Significantly Modulates the Power of Lipoprotein(a) to Predict Cardiovascular Events and Mortality in Young Coronary Artery Disease Patients
2021 · Arthur Mader, Maximilian Maechler, et al. · Circulation · 1
Abstract 8938: The New Myokine Myonectin is Significantly Associated with Type 2 Diabetes in Elderly Patients
2021 · Andreas Leiherer, Axel Muendlein, et al. · Circulation · 1
The new myokine myonectin is significantly associated with type 2 diabetes in elderly patients
2021 · A Leiherer, A Muendlein, et al. · European Heart Journal · 1
PDF
Type 2 diabetes, chronic kidney disease and major cardiovascular events in patients with established coronary artery disease
2021 · L Sprenger, A Vonbank, et al. · European Heart Journal · 1
PDF
Comparison of Two Recent Ceramide-based Coronary Risk Prediction Scores: Cert and Cert-2
2021 · Andreas Leiherer, Axel Muendlein, et al. · Journal of the American College of Cardiology · 1
Remnant Cholesterol in Patients With Established Coronary Artery Disease Predicts Cardiovascular Events Both Among Patients With Type 2 Diabetes and Among Non-diabetic Subjects
2021 · Christoph H. Saely, Maximilian Maechler, et al. · Journal of the American College of Cardiology · 1
The New Myokine Myonectin Is Significantly Associated With Type 2 Diabetes in Patients With Peripheral Artery Disease
2021 · Axel Muendlein, Kathrin Geiger, et al. · Journal of the American College of Cardiology · 1
Chronic Kidney Disease Is a Type 2 Diabetes Risk Equivalent in Patients With Established Coronary Artery Disease
2021 · Christoph H. Saely, Lukas Sprenger, et al. · Journal of the American College of Cardiology · 1
Abstract 8912: The Ceramide- and Phosphatidylcholine- Based Coronary Event Risk Test2 (CERT2) and Cardiovascular Mortality in Men and Women with Type 2 Diabetes
2021 · Andreas Leiherer, Axel Muendlein, et al. · Circulation
Abstract 8920: Type 2 Diabetes, Chronic Kidney Disease and Major Cardiovascular Events in Patients with Established Coronary Artery Disease
2021 · Lukas Sprenger, Alexander Vonbank, et al. · Circulation
Abstract 8964: Remnant Cholesterol in Patients With Established Cardiovascular Disease Predicts Cardiovascular Events Both Among Patients With Type 2 Diabetes and Among Non-Diabetic Subjects
2021 · Arthur Mader, Lukas Sprenger, et al. · Circulation
Abstract 8943: Type 2 Diabetes and Risk of Major Cardiovascular Events in Peripheral Artery Disease versus Coronary Artery Disease Patients
2021 · Christoph H Saely, Alexander Vonbank, et al. · Circulation
The ceramide- and phosphatidylcholine- based Coronary Event Risk Test2 (CERT2) and cardiovascular mortality in men and women with type 2 diabetes
2021 · A Leiherer, A Muendlein, et al. · European Heart Journal
Type 2 diabetes and risk of major cardiovascular events in peripheral artery disease versus coronary artery disease patients
2021 · C H Saely, A Vonbank, et al. · European Heart Journal
PDF
Type 2 diabetes significantly modulates the power of lipoprotein(a) to predict cardiovascular events and mortality in young coronary artery disease patients
2021 · A Mader, M Maechler, et al. · European Heart Journal
PDF
Remnant cholesterol in patients with established cardiovascular disease predicts cardiovascular events both among patients with type 2 diabetes and among non-diabetic subjects
2021 · A Mader, L Sprenger, et al. · European Heart Journal
PDF
Single and joint impact of type 2 diabetes and of congestive heart failure on Albuminuria
2021 · M. Maechler, A. Vonbank, et al. · Atherosclerosis
Type 2 diabetes and risk of cardiovascular events in peripheral artery disease versus coronary artery disease patients
2021 · L. Sprenger, A. Vonbank, et al. · Atherosclerosis
Works count: 45
Citation count: 553
H-index: 5
I10-index: 5
Year
Topic
Type